ApArTe
0695.571.855 · rovalta.com · 09/11/2026
ACTIVE
ApArTe
Financial year 2025 · Closed on 31/12/2025
Net result56,8 k €+13,6 %over 1 year
Gross margin66,5 k €+14,3 %over 1 year
Equity506,8 k €+1,4 %over 1 year
Overview
Identity
Source · BCE/KBOApArTe is a Private company with limited liability incorporated in 2018. Its main activity is: Management consultancy activities. Its registered office is in Arendonk.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0695.571.855
- Incorporation
- 27/04/2018
- Legal form
- Private company with limited liability
- Registered office
- Vrijheid 42
2370 Arendonk · FlandreSee on map - Contributed capital
- 450 000,00 €
- Latest accounts
- 31/12/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 7 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 66,5 k € | +14.3% | 58,1 k € | +138% | 24,4 k € | +5.5% | 23,2 k € | -91.1% | 259,9 k € |
| EBITDA | 65,3 k € | +14.6% | 57 k € | +145% | 23,3 k € | +5.5% | 22,1 k € | -91.5% | 258,9 k € |
| Operating result | 65,3 k € | +14.6% | 57 k € | +145% | 23,3 k € | +5.5% | 22,1 k € | -91.5% | 258,9 k € |
| Net result | 56,8 k € | +13.6% | 50 k € | +140% | 20,8 k € | +13.0% | 18,4 k € | -90.6% | 196,5 k € |
| Balance sheet | |||||||||
| Equity | 506,8 k € | +1.4% | 500 k € | -43.2% | 881 k € | +2.4% | 860,2 k € | +2.2% | 841,8 k € |
| Total assets | 1,2 M € | +3.3% | 1,1 M € | -2.6% | 1,2 M € | -6.0% | 1,2 M € | -8.6% | 1,4 M € |
| Cash | 56 k € | +9.3% | 51,2 k € | -7.2% | 55,2 k € | -26.1% | 74,7 k € | -29.8% | 106,4 k € |
| Debts | 674 k € | +4.7% | 643,5 k € | +120% | 293 k € | -24.7% | 389,2 k € | -26.0% | 525,7 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20253 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Ann Moriaux | Directorsince 27/04/2018 | ||
| Directorsince 27/04/2018 | |||
| Directorsince 27/04/2018 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 01/07/2026 | 01/07/2025 | 01/07/2024 | 03/07/2023 | 04/07/2022 | 01/07/2021 |
| General meeting | 30/06/2026 | 30/06/2025 | 29/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 30/06/2026 | 01/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/06/2025 | 01/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 29/06/2024 | 01/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 30/06/2023 | 03/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 30/06/2022 | 04/07/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/06/2021 | 01/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 30/06/2020 | 13/07/2020 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Ann Moriaux | Directorsince 27/04/2018 | ||
| Directorsince 27/04/2018 | |||
| Directorsince 27/04/2018 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings7 filings
Mandates
The Pharmacist
DUMOVEN
Ann Moriaux
201820192020202120222023202420252026
ApArTe
Vrijheid 42, 2370 Arendonk
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Vrijheid 42, 2370 ArendonkCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00244905 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| ApArTeCurrent | accounts 2019 → 2025 | Accounts 2025 · 2026-00244905 |
Events
- 2025Annual accounts 202556,8 k €↑
- 2024Annual accounts 202450 k €↑
- 2023Annual accounts 202320,8 k €↑
- 2022Annual accounts 202218,4 k €↓
- 2021Annual accounts 2021196,5 k €↑
- 2020Annual accounts 2020194 k €↑
- 2019Annual accounts 20191,3 k €
- 27/04/2018IncorporationPrivate company with limited liability